Skip to main content

Table 3 Neurodevelopmental evaluation according to SARS-CoV-2 delta variant

From: The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study

 

SARS-CoV-2 (+)

Delta (+) variant

(n = 11)

SARS-CoV-2 (+)

Delta (-) variant (n = 19)

P

MDI mean ± SDS

86.36 ± 11.91

89.75 ± 12.82

0.03

PDI mean ± SDS

87.50 ± 5.11

90.05 ± 7.18

0.03

NDI* Positivity n (%)

0

2 (10.5)

0.57

MDP n (%)

9 (81.8)

4 (21)

0.006

Blindness n (%)

0

0

NS

Deafness n (%)

0

0

NS

CP n (%)

0

0

NS

Need for Physical Therapy n (%)

1 (9)

0

0.63

Need for Special Education n (%)

1 (9)

0

0.63

  1. MDI- Mental developmental index, PDI- Psychomotor developmental index, NDI*- Neurodevelopmental retardation index defined as the presence of one or more of the following: (1) Moderate to severe cerebral palsy with functional losses, (2) Bilateral hearing loss and blindness, (3) Bayley-II MDI or PDI score < 70, MDP- Mildly delayed performance, defined as the presence of Bayley-II MDI or PDI score 70–84, CP - Cerebral palsy
Back to article page

Italian Journal of Pediatrics

ISSN: 1824-7288

Contact us